Rigel Pharmaceuticals
RIGL
#7539
Rank
S$0.40 B
Marketcap
$23.16
Share price
-0.70%
Change (1 day)
38.56%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.20 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are S$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.19 B-2.83%
2022-12-31S$0.19 B7.09%
2021-12-31S$0.18 B83.3%
2020-12-31S$0.10 B-20.09%
2019-12-31S$0.12 B216.51%
2018-12-31S$39.93 M61.7%
2017-12-31S$24.69 M-26.15%
2016-12-31S$33.44 M-41.43%
2015-12-31S$57.09 M66.92%
2014-12-31S$34.2 M51.62%
2013-12-31S$22.56 M-11.93%
2012-12-31S$25.61 M-5.62%
2011-12-31S$27.14 M2.46%
2010-12-31S$26.48 M-38.89%
2009-12-31S$43.34 M-23.64%
2008-12-31S$56.76 M17.38%
2007-12-31S$48.36 M21.25%
2006-12-31S$39.88 M-38.7%
2005-12-31S$65.06 M50.39%
2004-12-31S$43.26 M63.76%
2003-12-31S$26.42 M-19.44%
2002-12-31S$32.79 M1.19%
2001-12-31S$32.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$97.74 M-53.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$86.88 B 41,519.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$112.95 B 54,007.95%๐Ÿ‡บ๐Ÿ‡ธ USA